UnitedHealth Group (NYSE:UNH) Price Target Raised to $365.00 at Truist Financial

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price target lifted by equities research analysts at Truist Financial from $310.00 to $365.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has a "buy" rating on the healthcare conglomerate's stock. Truist Financial's target price points to a potential upside of 5.90% from the stock's current price.

• As the Market Rotates, This Healthcare ETF Is Leading the Way

Other equities research analysts also recently issued reports about the company. Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Barclays lifted their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a report on Thursday, September 4th. TD Securities reaffirmed a "hold" rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Wolfe Research cut their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. Finally, Hsbc Global Res downgraded shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $355.77.

Check Out Our Latest Stock Analysis on UNH

UnitedHealth Group Trading Up 7.6%

• Top 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cuts

UnitedHealth Group stock traded up $24.41 during trading hours on Tuesday, reaching $344.66. The company had a trading volume of 22,323,902 shares, compared to its average volume of 12,860,278. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a 50-day moving average price of $288.96 and a 200 day moving average price of $371.54. The firm has a market cap of $312.15 billion, a price-to-earnings ratio of 14.90, a P/E/G ratio of 2.04 and a beta of 0.45. UnitedHealth Group has a 12-month low of $234.60 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current year.

Institutional Investors Weigh In On UnitedHealth Group

• Renaissance Hedge Fund Adds NVIDIA, Follows Buffett Into UNH

Several hedge funds and other institutional investors have recently modified their holdings of UNH. Citizens National Bank Trust Department grew its position in shares of UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after buying an additional 170 shares during the last quarter. Fort Washington Investment Advisors Inc. OH grew its position in UnitedHealth Group by 0.3% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after purchasing an additional 1,465 shares during the last quarter. Caitlin John LLC grew its position in UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock worth $451,000 after purchasing an additional 111 shares during the last quarter. Sherbrooke Park Advisers LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $515,000. Finally, Silvercrest Asset Management Group LLC boosted its holdings in shares of UnitedHealth Group by 47.8% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock valued at $19,625,000 after acquiring an additional 12,550 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

• Five stocks we like better than UnitedHealth Group
• Why is the Ex-Dividend Date Significant to Investors?
• Casey’s General Stores: Investors Win With CASY at the Bat
• How to Calculate Options Profits
• 3 Potential Rate Cut Winners for Your Portfolio
• What is the Dogs of the Dow Strategy? Overview and Examples
• Joby's Stock Is Quiet, But a Storm of Catalysts Is Brewing

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here